| Date | Time | Source | Headline | Symbol | Company |
| 06/19/2008 | 7:50AM | PR Newswire (US) | Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated S | NYSE:FRX | Forest Road Acquisition Corp |
| 06/02/2008 | 4:35PM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 05/30/2008 | 12:28PM | Edgar (US Regulatory) | Forest Laboratories Inc - Annual Report (10-K) | NYSE:FRX | Forest Road Acquisition Corp |
| 05/20/2008 | 6:30PM | PR Newswire (US) | Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Result | NYSE:FRX | Forest Road Acquisition Corp |
| 05/20/2008 | 11:30AM | PR Newswire (US) | Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic f | NYSE:FRX | |
| 05/16/2008 | 3:54PM | PR Newswire (US) | /C O R R E C T I O N -- Forest Laboratories, Inc./ | NYSE:FRX | Forest Road Acquisition Corp |
| 05/15/2008 | 1:22PM | PR Newswire (US) | Forest Laboratories, Inc. and Laboratorios Almirall, S.A. to Host Webcast to Discuss Aclidinium Bromide Data Presentations at th | NYSE:FRX | Forest Road Acquisition Corp |
| 05/12/2008 | 8:45AM | PR Newswire (US) | Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement | NYSE:FRX | Forest Road Acquisition Corp |
| 05/07/2008 | 12:00PM | PR Newswire (US) | Study Demonstrates Lexapro(R) Significantly Improves Depression Symptoms in Adolescents | NYSE:FRX | Forest Road Acquisition Corp |
| 04/16/2008 | 11:31AM | Edgar (US Regulatory) | Forest Laboratories Inc - Current report filing (8-K) | NYSE:FRX | Forest Road Acquisition Corp |
| 04/15/2008 | 8:50AM | PR Newswire (US) | Forest Laboratories, Inc. Reports Fiscal Year 2008 Fourth Quarter Reported EPS of $0.55 Including $0.35 Per Share Charge for Lic | NYSE:FRX | Forest Road Acquisition Corp |
| 04/10/2008 | 4:20PM | Edgar (US Regulatory) | Forest Laboratories Inc - Amended Annual Report (10-K/A) | NYSE:FRX | Forest Road Acquisition Corp |
| 04/08/2008 | 3:22PM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 04/07/2008 | 1:33PM | PR Newswire (US) | Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Fourth Quarter Earnings | NYSE:FRX | Forest Road Acquisition Corp |
| 04/01/2008 | 5:26PM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 03/20/2008 | 10:16AM | Edgar (US Regulatory) | Forest Laboratories Inc - Current report filing (8-K) | NYSE:FRX | Forest Road Acquisition Corp |
| 03/19/2008 | 8:12AM | PR Newswire (US) | Forest Laboratories Announces Resignation of Ivan Gergel, MD | NYSE:FRX | Forest Road Acquisition Corp |
| 03/04/2008 | 6:04PM | PR Newswire (US) | Microbia and Forest Laboratories Announce Preliminary Results of Linaclotide Phase 2b Studies | NYSE:FRX | Forest Road Acquisition Corp |
| 03/03/2008 | 4:36PM | Edgar (US Regulatory) | Forest Laboratories Inc - Current report filing (8-K) | NYSE:FRX | Forest Road Acquisition Corp |
| 02/27/2008 | 4:20PM | PR Newswire (US) | Mylan Announces Amendment to Bystolic(TM) (Nebivolol) Agreement | NYSE:FRX | Forest Road Acquisition Corp |
| 02/27/2008 | 4:17PM | PR Newswire (US) | Forest Laboratories, Inc. Announces Amendment to Bystolic(TM) (nebivolol) Agreement | NYSE:FRX | Forest Road Acquisition Corp |
| 02/27/2008 | 10:23AM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 02/27/2008 | 10:13AM | Edgar (US Regulatory) | Forest Laboratories Inc - Amended Statement of Ownership (SC 13G/A) | NYSE:FRX | Forest Road Acquisition Corp |
| 02/21/2008 | 5:48PM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 02/21/2008 | 8:00AM | Marketwired | Forest and Cypress Announce FDA Acceptance for Review of New Drug Application for Milnacipran for the Treatment of Fibromyalgia | NYSE:FRX | Forest Road Acquisition Corp |
| 02/14/2008 | 1:33PM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 02/14/2008 | 12:09PM | Edgar (US Regulatory) | Forest Laboratories Inc - Schedule 13G (SC 13G/A) | NYSE:FRX | Forest Road Acquisition Corp |
| 02/14/2008 | 10:55AM | Edgar (US Regulatory) | Forest Laboratories Inc - Amended Statement of Ownership (SC 13G/A) | NYSE:FRX | Forest Road Acquisition Corp |
| 02/12/2008 | 5:15PM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 02/12/2008 | 12:18PM | Edgar (US Regulatory) | Forest Laboratories Inc - Amended Statement of Ownership (SC 13G/A) | NYSE:FRX | Forest Road Acquisition Corp |